APO-Metformin (2020-06-12)

Health Products

Jun 12, 2020

Alert type: Drug Recall

Category: Drugs

Issue: Product Safety

Audience: General Public, Healthcare Professionals, Hospitals

Department: Health Canada

Hazard classification: Type I

APO-Metformin 500 mg Extended Release Tablet

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

CA$3.99/mo · cancel anytime

Lot or serial number	Companies	Brand name	DIN, NPN, DIN-HIM	Dosage form	Strength
PK3968	Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA	APO-Metformin 500 mg Extended Release Tablet	DIN 02305062	Tablet (Extended Release)	Metformin hydrochloride 500 mg

Affected lots contain or may contain the presence of N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.

Wholesalers, Retailers

CA$3.99/mo · cancel anytime